from web site
Item Description, SARS-COV2 Antigen Rapid Test Card contains a gold-labeled unique coronavirus N protein monoclonal antibody pre-coated on the bonding pad and a paired novel coronavirus N protein monoclonal antibodies xed in the test line (T) and corresponding antibodies in the quality control line (C). SARS-COV2 Antigen Quick Test Kit can identify the virus from the rst phase of infection (2-3 days prior to prospective sign onset) to the last phase of infection (7-10 days after possible symptom beginning).
Gold-labelled SARS-Co, V-2 N protein monoclonal antibodies incapacitated on the test location, with matching antibodies in the quality assurance location. The Latest Info Found Here from the nasopharynx or oropharyngeal, result in 15 minutes. Item Functions Non-invasive Simple to use Convenient, no gadgets needed Fast, get a lead to 15 minutes Steady, with high precision Inexpensive, cost-efficiency, Related News, On 26th Jan 2021, report from PEI of a main test that The Federal Institute for Drugs and Medical Gadget (Bundesinstitut fr Arzneimittel und Medizinprodukte, Bf, Ar, M) authorized to carry out, declared that Lepu Medical SARS-Co, V-2 Antigen Fast Test Set has fulfilled all the minimum requirements for antigen tests performed by PEI in assessment with the Robert Koch-Institut (RKI).
The test package makes the coronavirus detection treatments fast and simple.
The performance of the package was developed utilizing scientific samples, with package results compared to nucleic acid test results. The package revealed sensitivity of 96. 330% and specificity of 99. 569%. In addition, separate oropharyngeal swabs, nasal swabs and nasopharyngeal swabs were collected from 50 clients and compared for homologous consistency.
This SARS-Co, V-2 antigen rapid test kit does not cross-react with samples of: Staphylococcus aureus, Streptococcus pneumoniae, measles virus, mumps infection, adenovirus type 3, Mycoplasma pneumoniae, parainfluenza infection type 2, metapneumovirus, coronavirus OC43, coronavirus 229E, Bacillus parapertussis, Type B influenza virus Victoria line, Type B influenza infection Y line, Type A influenza virus H1N1, Type A influenza infection H3N2, Avian influenza virus H7N9, Avian influenza infection H5N1, Epstein-Barr infection, Enterovirus CA16, Rhinovirus.
This package is for scientific in vitro diagnosis only. Please read the directions carefully prior to screening, and operate in rigorous accordance with the guidelines. Different batches of reagents and treatment solutions must not be blended. Sample collection, storage and screening must be in stringent accordance with the unique Coronavirus related screening technical guides and biosafety guides.